Lourenco MV, Clarke JR, Frozza RL, Bomfim TR, Forny-Germano L, Batista AF, et al
Clinical trial data for GLP-1 medicines, including Ozempic, Mounjaro, Wegovy/Wegovy HD, Zepbound, and Foundayo, were reviewed to compare reported weight-loss results, FDA-approved uses, and study limitations
If User does not understand or agree with any of the terms of this Agreement, do not purchase from the Website
Semaglutide Both Tirzepatide and Semaglutide are helpful for weight loss and blood sugar control
After stopping, it takes roughly 5 half-lives (about 30 days) for the compound to clear
Unlike semaglutide which activates only GLP-1 receptors, or tirzepatide which targets GLP-1 and GIP, retatrutide simultaneously activates three hormone receptors